Exciting Leadership Change at HSS
Hospital for Special Surgery (HSS) has made an important announcement regarding its leadership in the field of endocrinology. The appointment of Dr. Matthew T. Drake, MD, PhD, as the chief of the Division of Endocrinology and director of the Metabolic Bone Service will usher in a new chapter for HSS. Dr. Drake is set to begin his new role on January 1, 2025, succeeding Dr. Emily Stein, who has effectively managed the division since March 2023.
About Dr. Matthew T. Drake
Dr. Drake comes to HSS with a wealth of experience and expertise in endocrinology. Since 2007, he has been a consultant in the Division of Endocrinology, Diabetes, Metabolism, and Nutrition at the prestigious Mayo Clinic in Rochester. Additionally, he took on a dual role as a consultant in Mayo's Division of Hematology in 2017, underscoring his diverse skill set and collaborative nature. His academic contributions are equally impressive, being an Associate Professor of Medicine at the Mayo Clinic College of Medicine and Science since 2015.
Visionary Leadership
Dr. Drake's vision for the Division of Endocrinology at HSS emphasizes a commitment to excellence in clinical, educational, and investigational programs. He aims to enhance patient experiences and outcomes through collaboration with both HSS physicians and staff. This cooperative spirit is essential, particularly when identifying and addressing risk factors in bone health that could influence surgical outcomes, especially in areas like joint replacement and sports medicine.
Community Commitment
“Dr. Drake is an internationally recognized endocrinologist, and we are thrilled to have him join our team,” expressed Dr. S. Louis Bridges, Jr., the physician-in-chief at HSS. Dr. Bridges emphasized the vital role that Dr. Drake's extensive experience will play in maintaining HSS's leadership in the diagnosis and treatment of endocrine and metabolic bone diseases. Dr. Drake himself remarked on the privilege of joining HSS, citing its stellar reputation and commitment to patient care.
Innovative Research Initiatives
Dr. Drake's arrival also marks a significant opportunity for advancing research at HSS. Known for his groundbreaking work, he has received multiple research grants from the National Institutes of Health. He intends to collaborate closely with leaders in the HSS Research Institute, the Department of Orthopedics, and the Division of Rheumatology to prioritize impactful investigations that will push the boundaries of current medical knowledge.
Research Focus
With a research background centered on age-related bone loss and the effects of cancer on bone health, Dr. Drake's work could lead to new therapeutic methods for preventing and treating such conditions. His scholarly output includes over 125 peer-reviewed articles and numerous book chapters focusing on osteoporosis, myeloma bone disease, and calcium metabolism disorders.
Outstanding Academic Background
Dr. Drake graduated Magna Cum Laude from Harvard College, where he received his AB degree in Biology. He then obtained his MD and PhD in Molecular and Cell Biology from Washington University. His comprehensive training includes completing a residency in Internal Medicine and Endocrinology at Duke University Medical Center, coupled with clinical research fellowships that solidified his expertise in the field.
The Future at HSS
HSS's commitment to patient care and the advancement of healthcare practices continues with the recruitment of exceptional leaders like Dr. Drake. Dr. Douglas E. Padgett, surgeon-in-chief, noted that the dedication displayed by Drs. Drake and Stein in the field of endocrinology reflects HSS's continuous pursuit of high-quality, impactful healthcare for its patients.
About HSS
HSS stands as a beacon of excellence in musculoskeletal health, consistently ranked as the leading center in orthopedics for over 15 years. U.S. News & World Report ranks HSS No. 1 in orthopedics, while it holds notable placements in rheumatology as well. The institution prides itself on its low readmission rates and a commitment to patient care that resonates on both national and international levels.
Founded in 1863, HSS is not only a medical center but a hub for innovative research and education within the field of musculoskeletal health. The HSS Research Institute, alongside more than 200 clinical investigators, works fervently to enhance patient outcomes and develop novel treatment modalities in orthopedic and musculoskeletal diseases.
Frequently Asked Questions
Who is Dr. Matthew T. Drake?
Dr. Matthew T. Drake is a recognized expert in endocrinology, recently appointed as the chief of the Division of Endocrinology and director of the Metabolic Bone Service at HSS.
What experience does Dr. Drake have?
Dr. Drake has been a consultant at the Mayo Clinic since 2007 and has significant experience in clinical and research settings, holding an associate professorship since 2015.
What will Dr. Drake's role involve?
His role encompasses overseeing clinical programs, optimizing patient outcomes, and collaborating with HSS staff and researchers in bone health topics.
How does HSS rank in musculoskeletal health?
HSS consistently ranks No. 1 in orthopedics and occupies high rankings in other specialties, known for its quality of patient care and innovative research.
What is HSS's mission?
HSS aims to provide exceptional musculoskeletal care through leading-edge research, high-quality education, and innovative treatment methods on a global scale.
